Literature DB >> 18053450

Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies.

Nikhil C Munshi.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18053450     DOI： 10.1016/S0025-6196(11)61086-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  8 in total

1.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.

Authors:  Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

2.  With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Authors:  Nathanael R Fillmore; Sarvari V Yellapragada; Chizoba Ifeorah; Ansh Mehta; Diana Cirstea; Paul S White; Gustavo Rivero; Andrew Zimolzak; Saiju Pyarajan; Nhan Do; Mary Brophy; Nikhil C Munshi
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

3.  High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.

Authors:  Francis Buadi; Ann W Hsing; Jerry A Katzmann; Ruth M Pfeiffer; Adam Waxman; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew Adjei; Lisa W Chu; Angelo DeMarzo; George J Netto; Angela Dispenzieri; Robert A Kyle; S Vincent Rajkumar; Ola Landgren
Journal:  Am J Hematol       Date:  2011-06-14       Impact factor: 10.047

Review 4.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

5.  Prevalence of monoclonal gammopathy of undetermined significance in Thailand.

Authors:  Phandee Watanaboonyongcharoen; Thanyaphong Na Nakorn; Ponlapat Rojnuckarin; Panisinee Lawasut; Tanin Intragumtornchai
Journal:  Int J Hematol       Date:  2012-01-12       Impact factor: 2.490

6.  Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Authors:  Giada Bianchi; Robert A Kyle; Colin L Colby; Dirk R Larson; Shaji Kumar; Jerry A Katzmann; Angela Dispenzieri; Terry M Therneau; James R Cerhan; L Joseph Melton; S Vincent Rajkumar
Journal:  Blood       Date:  2010-05-21       Impact factor: 22.113

7.  Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.

Authors:  S Ailawadhi; A Swaika; P Razavi; D Yang; A Chanan-Khan
Journal:  Blood Cancer J       Date:  2014-09-05       Impact factor: 11.037

8.  Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.

Authors:  Normann Steiner; Georg Göbel; Hannes Neuwirt; Eberhard Gunsilius; Patricia Suchecki; Wolfgang Prokop
Journal:  Oncotarget       Date:  2017-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.